KMT2A rearrangements involve a variety of fusion partner genes though the most common observed in T-ALL include epigenetic regulators MLLT1 and MLLT4, and less commonly, MLLT3 and MLLT10 [65–67]. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.